Literature DB >> 10594380

Stability of SUV liposomes in the presence of cholate salts and pancreatic lipases: effect of lipid composition.

M Kokkona1, P Kallinteri, D Fatouros, S G Antimisiaris.   

Abstract

The effect of bile salts (sodium cholate and sodium taurocholate), and pancreatic lipases on the structural integrity of SUV liposomes of different lipid compositions was studied. Liposomal membrane integrity was judged by bile salt or pancreatin-induced release of vesicle encapsulated 5,6-carboxyfluorescein, and vesicle size distribution before and after incubations. Bile salt concentration was 10 mM, while a saturated solution of pancreatin (mixed with equal volume of liposomes) was utilized. Results agree with earlier studies, demonstrating the instability of liposomes composed of lipids with low transition temperatures (PC and DMPC) in presence of cholates. Addition of cholesterol (1:1 lipid:chol molar ratio) does not substantially increase the encapsulated molecule retention. Nevertheless, liposomes composed of lipids with high transition temperatures (DPPC, DSPC and SM), retain significantly higher amounts of encapsulated material, under all conditions studied. Furthermore, the vesicles formed by mixing cholesterol with these lipids will possibly be sufficiently stable in the gastrointestinal tract for long periods of time. Sizing results reveal that in most cases release of encapsulated molecules is mainly caused by their leakage through holes formed on the lipid bilayer. However, in stearylamine containing DPPC and DSPC vesicles, the cholate-induced drastic decrease in vesicle size suggests total liposome disruption as the possible mechanism of encapsulated material immediate release.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10594380     DOI: 10.1016/s0928-0987(99)00064-0

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  10 in total

1.  Colloidal structures in media simulating intestinal fed state conditions with and without lipolysis products.

Authors:  Dimitrios G Fatouros; Isabelle Walrand; Bjorn Bergenstahl; Anette Müllertz
Journal:  Pharm Res       Date:  2008-11-12       Impact factor: 4.200

2.  Mono and dually decorated nanoliposomes for brain targeting, in vitro and in vivo studies.

Authors:  E Markoutsa; K Papadia; A D Giannou; M Spella; A Cagnotto; M Salmona; G T Stathopoulos; S G Antimisiaris
Journal:  Pharm Res       Date:  2013-12-13       Impact factor: 4.200

Review 3.  Emerging research and clinical development trends of liposome and lipid nanoparticle drug delivery systems.

Authors:  John C Kraft; Jennifer P Freeling; Ziyao Wang; Rodney J Y Ho
Journal:  J Pharm Sci       Date:  2013-11-25       Impact factor: 3.534

4.  Secretory phospholipase A₂ responsive liposomes.

Authors:  Guodong Zhu; Jason N Mock; Ibrahim Aljuffali; Brian S Cummings; Robert D Arnold
Journal:  J Pharm Sci       Date:  2011-03-31       Impact factor: 3.534

5.  Chitosan-Coated Liposomes: The Strategy to Reduce Intestinal Toxicity and Improve Bioavailability of Oral Vinorelbine.

Authors:  Chen Guo; Xichun Zhu; Haoyang Yuan; Haoyu Liu; Yu Zhang; Tian Yin; Haibing He; Jingxin Gou; Xing Tang
Journal:  AAPS PharmSciTech       Date:  2022-06-10       Impact factor: 3.246

6.  Thiolated Chitosan Conjugated Liposomes for Oral Delivery of Selenium Nanoparticles.

Authors:  Atiđa Selmani; Elisabeth Seibert; Carolin Tetyczka; Doris Kuehnelt; Ivan Vidakovic; Karin Kornmueller; Markus Absenger-Novak; Borna Radatović; Ivana Vinković Vrček; Gerd Leitinger; Eleonore Fröhlich; Andreas Bernkop-Schnürch; Eva Roblegg; Ruth Prassl
Journal:  Pharmaceutics       Date:  2022-04-06       Impact factor: 6.525

7.  Pulmonary collectins selectively permeabilize model bacterial membranes containing rough lipopolysaccharide.

Authors:  Alexander I Kuzmenko; Huixing Wu; Francis X McCormack
Journal:  Biochemistry       Date:  2006-02-28       Impact factor: 3.162

Review 8.  Multifaceted applications of bile salts in pharmacy: an emphasis on nanomedicine.

Authors:  Yosra S R Elnaggar
Journal:  Int J Nanomedicine       Date:  2015-06-12

9.  Optimization on condition of epigallocatechin-3-gallate (EGCG) nanoliposomes by response surface methodology and cellular uptake studies in Caco-2 cells.

Authors:  Xiaobo Luo; Rongfa Guan; Xiaoqiang Chen; Miao Tao; Jieqing Ma; Jin Zhao
Journal:  Nanoscale Res Lett       Date:  2014-06-10       Impact factor: 4.703

Review 10.  Drug Delivery Systems for the Oral Administration of Antimicrobial Peptides: Promising Tools to Treat Infectious Diseases.

Authors:  Caroline Deshayes; Md Nasir Arafath; Véronique Apaire-Marchais; Emilie Roger
Journal:  Front Med Technol       Date:  2022-01-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.